ArticleRheumatology and therapy2021

Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis.

Steven L Truong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.